연구
연구업적
최근 5년 연구업적 현황
| 연도 | 2025년 | 2024년 | 2023년 | 2022년 | 2021년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 196편 | 179편 | 173편 | 163편 | 184편 |
| 공동 | 132편 | 147편 | 120편 | 115편 | 136편 | |
| 합계 | 328편 | 326편 | 293편 | 278편 | 320편 | |
2815. Subcellular progression of mesenchymal transition identified by two discrete synchronous cell lines derived from the same glioblastoma
Sojin Kim # 1 2, Soo-Ji Park # 3 4, Tamrin Chowdhury # 1, Jeong-Im Hong 3, Jinhee Ahn 3, Tae Yeong Jeong 3 4, Hyeon Jong Yu 1, Young-Kyoung Shin 5, Ja-Lok Ku 5, Jong Bae Park 6, Junho K Hur 7, Hwajin Lee 8, Kyoungmi Kim 9 10, Chul-Kee Park 11 12
Cell Mol Life Sci. 2022 Mar 12;79(3):181.
Link
2814. The telomere maintenance mechanism spectrum and its dynamics in gliomas
Sojin Kim # 1, Tamrin Chowdhury # 1 2, Hyeon Jong Yu 1 2, Jee Ye Kahng 2, Chae Eun Lee 1, Seung Ah Choi 1 3, Kyung-Min Kim 1 2, Ho Kang 1 2, Joo Ho Lee 2 4, Soon-Tae Lee 2 5, Jae-Kyung Won 2 6, Kyung Hyun Kim 1 3, Min-Sung Kim 1, Ji Yeoun Lee 1 3 7, Jin Wook Kim 1 2, Yong-Hwy Kim 1 2, Tae Min Kim 2 8, Seung Hong Choi 2 9, Ji Hoon Phi 2 3, Young-Kyoung Shin 2 10, Ja-Lok Ku 2 10, Sungyoung Lee 11, Hongseok Yun 11, Hwajin Lee 12, Dokyoung Kim 13, Kyoungmi Kim 14, Junho K Hur 15, Sung-Hye Park 2 6,
Genome Med. 2022 Aug 11;14(1):88
Link
2813. Involvement of cell shape and lipid metabolism in glioblastoma resistance to temozolomide
Munki Choo 1, Van-Hieu Mai 1, Han Sun Kim 1, Dong-Hwa Kim 1, Ja-Lok Ku 2, Sang Kook Lee 1, Chul-Kee Park 3, Yong Jin An 4, Sunghyouk Park 5
Acta Pharmacol Sin. 2022 Sep 13.
Link
2812. Ibrutinib Treatment of Pediatric Chronic Graft-versus-Host Disease: Primary Results from the Phase 1/2 iMAGINE Study.
Carpenter PA, Kang HJ, Yoo KH, Zecca M, Cho B, Lucchini G, Nemecek ER, Schultz KR, Stepensky P, Chaudhury S, Oshrine B, Khaw SL, Harris AC, Verna M, Zubarovskaya L, Lee Y, Wahlstrom J, Styles L, Shaw PJ, Dalle JH.
Transplant Cell Ther, 2022 Nov, 28(11):771.e1-771.e10.
Link
2811. Clinical Characteristics and Prognosis of the Modified Probable Pneumocystis jirovecii Pneumonia in Korean Children, 2001-2021.
Yun KS, Anh B, Choi SH, Hong KT, Choi JY, Yun KW, Kang HJ, Choi EH.
Children (Basel), 2022 Oct, 9(10):1596.
Link
2810. Clinical Outcome of Optic Pathway and Hypothalamic Gliomas: A 20-Year Single-Institution Retrospective Study.
Kim JW, Phi JH, Lee JY, Koh EJ, Kim KH, Kang HJ, Choi JY, Park SH, Wang KC, Kim SK.
World Neurosurg, 2022 Oct, 166:e451-e459.
Link
2809. Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors.
Doz F, van Tilburg CM, Geoerger B, Højgaard M, Øra I, Boni V, Capra M, Chisholm J, Chung HC, DuBois SG, Gallego-Melcon S, Gerber NU, Goto H, Grilley-Olson JE, Hansford JR, Hong DS, Italiano A, Kang HJ, Nysom K, Thorwarth A, Stefanowicz J, Tahara M, Ziegler DS, Gavrilovic IT, Norenberg R, Dima L, De La Cuesta E, Laetsch TW, Drilon A, Perreault S.
Neuro Oncol. 2021 Nov 27, 2022 Jun, 24(6):997-1007.
Link
2808. Outbreak of COVID-19 among children and young adults in a cancer centre daycare unit.
Yun KW, Kim YK, Song ES, An HY, Hong KT, Choi JY, Kang HJ, Chung SM, Park IK, Lee HY, Kim NJ, Choi EH.
Epidemiol Infect, 2022 Feb, 150:e40.1-5.
Link
2807. International retrospective study of allogeneic hematopoietic cell transplantation for activated PI3K-delta syndrome.
Dimitrova D, Nademi Z, Maccari ME, Ehl S, Uzel G, Tomoda T, Okano T, Imai K, Carpenter B, Ip W, Rao K, Worth AJJ, Laberko A, Mukhina A, Neven B, Moshous D, Speckmann C, Warnatz K, Wehr C, Abolhassani H, Aghamohammadi A, Bleesing JJ, Dara J, Dvorak CC, Ghosh S, Kang HJ, Markelj G, Modi A, Bayer DK, Notarangelo LD, Schulz A, Garcia-Prat M, Soler-Palacin P, Karakukcu M, Yilmaz E, Gambineri E, Menconi M, Masmas TN, Holm M, Bonfim C, Prando C, Hughes S, Jolles S, Morris EC, Kapoor N, Koltan S, Panees
J Allergy Clin Immunol, 2022 Jan, 149(1):410-421.
Link
2806. Clinical Characteristics and Treatment Outcomes of Childhood Acute Promyelocytic Leukemia in Korea: a Nationwide Multicenter Retrospective Study by Korean Pediatric Oncology Study Group.
Park KM, Yoo KH, Kim SK, Lee JW, Chung NG, Ju HY, Koo HH, Lyu CJ, Han SM, Han JW, Choi JY, Hong KT, Kang HJ, Shin HY, Im HJ, Koh KN, Kim H, Kook H, Baek HJ, Kim BR, Yang EJ, Lim JY, Park ES, Choi EJ, Park SK, Lee JM, Shim YJ, Kim JY, Park JK, Kong SK, Choi YB, Cho B, Lim YT.
Cancer Res Treat, 2022 Jan, 54(1):269-276.
Link